Cargando…

(−)-Epigallocatechin-3-gallate Inhibits Human and Rat Renal Organic Anion Transporters

[Image: see text] Organic anion transporter 1 (OAT1, SLC22A6) and 3 (OAT3, SLC22A8) are multispecific drug transporters highly expressed on the basolateral membranes of the renal proximal tubules. OAT1 and OAT3 mediate the tubular secretion of clinically significant drugs; thus, they influence the p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kawasaki, Tatsuya, Kondo, Masaki, Hiramatsu, Rioka, Nabekura, Tomohiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2021
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7893792/ https://www.ncbi.nlm.nih.gov/pubmed/33623845 http://dx.doi.org/10.1021/acsomega.0c05586

Ejemplares similares

Epigallocatechin gallate inhibits dimethylhydrazine-induced colorectal cancer in rats
por: Wang, Yu, et al.
Publicado: (2020)

Broad inhibition of plasmodium falciparum cytoadherence by (+)-epigallocatechin gallate
por: Patil, Pradeep R, et al.
Publicado: (2011)

In Vitro Toxicity of Epigallocatechin Gallate in Rat Liver Mitochondria and Hepatocytes
por: Kucera, Otto, et al.
Publicado: (2015)

Epigallocatechin-3-gallate counters cisplatin toxicity of rat testes
por: Fouad, Amr A., et al.
Publicado: (2017)

Skin Protective Effect of Epigallocatechin Gallate
por: Kim, Eunji, et al.
Publicado: (2018)

Role of Epigallocatechin Gallate in Glucose, Lipid, and Protein Metabolism and L-Theanine in the Metabolism-Regulatory Effects of Epigallocatechin Gallate
por: Lin, Ling, et al.
Publicado: (2021)

Identification of the Catechin Uptake Transporter Responsible for Intestinal Absorption of Epigallocatechin Gallate in Mice
por: Ishii, Shunsuke, et al.
Publicado: (2019)

Epigallocatechin-3-gallate inhibits doxorubicin-induced inflammation on human ovarian tissue
por: Fabbri, R, et al.
Publicado: (2019)

Inhibitory effects of epigallocatechin gallate and its glucoside on the human intestinal maltase inhibition
por: Nguyen, Thi Thanh Hanh, et al.
Publicado: (2012)

Epigallocatechin gallate inhibits the growth and promotes the apoptosis of bladder cancer cells
por: Feng, Chenchen, et al.
Publicado: (2017)

Epigallocatechin Gallate Nanodelivery Systems for Cancer Therapy
por: Granja, Andreia, et al.
Publicado: (2016)

Food-Grade Encapsulation Systems for (−)-Epigallocatechin Gallate
por: Shi, Meng, et al.
Publicado: (2018)

Therapeutic Potential of Epigallocatechin Gallate Nanodelivery Systems
por: Granja, Andreia, et al.
Publicado: (2017)

Effect of Epigallocatechin Gallate on Viability of Kudoa septempunctata
por: Shin, Sang Phil, et al.
Publicado: (2020)

Effects of epigallocatechin-3-gallate combined with ascorbic acid and glycerol on the stability and uric acid-lowering activity of epigallocatechin-3-gallate
por: Xie, Qianjin, et al.
Publicado: (2021)

The green tea extract epigallocatechin-3-gallate inhibits irradiation-induced pulmonary fibrosis in adult rats
por: YOU, HUA, et al.
Publicado: (2014)

(−)-Epigallocatechin-3-gallate (EGCG) attenuates salt-induced hypertension and renal injury in Dahl salt-sensitive rats
por: Luo, Dan, et al.
Publicado: (2020)

Food Inhibits the Oral Bioavailability of the Major Green Tea Antioxidant Epigallocatechin Gallate in Humans
por: Naumovski, Nenad, et al.
Publicado: (2015)

Epigallocatechin gallate inhibits hepatitis B virus infection in human liver chimeric mice
por: Lai, Yu-Heng, et al.
Publicado: (2018)

Epigallocatechin-3-gallate and Epigallocatechin-3-O-(3-O-methyl)-gallate Enhance the Bonding Stability of an Etch-and-Rinse Adhesive to Dentin
por: Yu, Hao-Han, et al.
Publicado: (2017)

Epigallocatechin-3 gallate prevents cardiac hypertrophy induced by pressure overload in rats
por: Hao, Jia, et al.
Publicado: (2007)

Cardioprotective effect of epigallocatechin-3-gallate against myocardial infarction in hypercholesterolemic rats
por: ZHONG, WEI, et al.
Publicado: (2015)

Epigallocatechin-3-Gallate Ameliorates Glucocorticoid-Induced Osteoporosis of Rats in Vivo and in Vitro
por: Liu, Shengye, et al.
Publicado: (2018)

Epigallocatechin‐3‐O‐gallate modulates the diversity of gut microbiota in ovariectomized rats
por: Zhang, Beilin, et al.
Publicado: (2020)

Effect of Topical Epigallocatechin-Gallate on Lipopolysaccharide-induced Pulpal Inflammation in Rat Models
por: Ismiyatin, Kun, et al.
Publicado: (2018)

Epigallocatechin gallate inhibits the proliferation of colorectal cancer cells by regulating Notch signaling
por: Jin, Heiying, et al.
Publicado: (2013)

Epigallocatechin-3-Gallate Inhibits Stem-Like Inflammatory Breast Cancer Cells
por: Mineva, Nora D., et al.
Publicado: (2013)

Epigallocatechin Gallate Inhibits Mouse Mesenchymal Stem Cell Differentiation to Adipogenic Lineage
por: Chani, Baldeep, et al.
Publicado: (2016)

Epigallocatechin-3-gallate inhibits osteoclastic differentiation by modulating mitophagy and mitochondrial functions
por: Sarkar, Jaganmay, et al.
Publicado: (2022)

Effects of Natural Polyphenols on the Expression of Drug Efflux Transporter P-Glycoprotein in Human Intestinal Cells
por: Nabekura, Tomohiro, et al.
Publicado: (2018)

Enhanced uptake and transport of (+)-catechin and (−)-epigallocatechin gallate in niosomal formulation by human intestinal Caco-2 cells
por: Song, Qinxin, et al.
Publicado: (2014)

Effects of (-)-epigallocatechin gallate on RPE cell migration and adhesion
por: Chan, Chi-Ming, et al.
Publicado: (2010)

Potential neuroprotective properties of epigallocatechin-3-gallate (EGCG)
por: Singh, Neha Atulkumar, et al.
Publicado: (2016)

Inhibitory Effects of (−)-Epigallocatechin-3-gallate on Esophageal Cancer
por: Wang, Liu-Xiang, et al.
Publicado: (2019)

The Effect of Ultrasound, Oxygen and Sunlight on the Stability of (−)-Epigallocatechin Gallate
por: Zeng, Jiajun, et al.
Publicado: (2018)

Melatonin and (−)-Epigallocatechin-3-Gallate: Partners in Fighting Cancer
por: Zhang, Lingyun, et al.
Publicado: (2019)

Anticancer effects and molecular mechanisms of epigallocatechin-3-gallate
por: Min, Kyoung-jin, et al.
Publicado: (2014)

Effects of Epigallocatechin-3-Gallate on Autophagic Lipolysis in Adipocytes
por: Kim, Sang-Nam, et al.
Publicado: (2017)

Preclinical Activities of Epigallocatechin Gallate in Signaling Pathways in Cancer
por: Sharifi-Rad, Mehdi, et al.
Publicado: (2020)

Epigallocatechin-3-Gallate as a Novel Vaccine Adjuvant
por: Cheong, Yucheol, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vjov5kvd1vlvr1jkfbko2cv3ek